Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis
Open Access
- 25 May 2016
- journal article
- research article
- Published by Springer Nature in Rheumatology and Therapy
- Vol. 3 (1) , 53-75
Abstract
The present study aimed to assess disease control, health resource utilization (HRU), and healthcare costs, and their predictors in gout patients across the USA, UK, Germany, and France.Keywords
This publication has 39 references indexed in Scilit:
- Glucose Lowering Therapeutic Strategies for Type 2 Diabetic Patients with Chronic Kidney Disease in Primary Care Setting in France: A Cross-Sectional StudyInternational Journal of Endocrinology, 2013
- Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional surveyHealth and Quality of Life Outcomes, 2012
- Health Care Utilization in Patients with GoutSeminars in Arthritis and Rheumatism, 2011
- Gout. Epidemiology of goutArthritis Research & Therapy, 2010
- The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trialArthritis Research & Therapy, 2010
- Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005Annals of the Rheumatic Diseases, 2008
- British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of GoutRheumatology, 2007
- Validity of gout diagnoses in administrative dataArthritis Care & Research, 2007
- EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)Annals of the Rheumatic Diseases, 2006
- EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT)Annals of the Rheumatic Diseases, 2006